Fig. 2. (A) Apelin-13 treatment improved muscle electromyography (EMG) activity in Huntington’s disease (HD) group. EMG was assessed in all experimental groups, as illustrated in this figure. (B) The EMG latency was sensibility expanded after 3-NP administration (***P<0.001), though it restored in Apelin-13 rats (*P<0.5).

Anat Cell Biol 2024;57:419~430 https://doi.org/10.5115/acb.23.284

© Anat Cell Biol